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Abstract 
Asexual blood stage proliferation is responsible for 
the morbidity and mortality associated with malaria 
infection in man. These developmental stages are 
therefore obvious targets for the development of 
malaria vaccines. Several asexual blood stage compo- 
nents have been identified as potential candidates for 
the development of vaccines and some of them have 
been shown, following immunization, to induce at 
least partial protection in a variety of Plasmodium-host 
combinations. Studies on defined parasite compo- 
nents and on synthetic peptides derived from them 
have revealed new insights at the molecular level into 
parasite mechanisms involved in propagation and 
survival in the infected host, and into the interaction 
between parasite components and the host immune 
system. practical application of these findings is likely 
to provide the basis for the design of more appropriate 
antigens for the development of vaccines. 
Introduction 
Epidemiological studies have shown that the de- 
velopment of resistance to malaria in man depends on 
both the degree and the duration of exposure to the 
parasite. A primary malaria infection is not followed 
by the development of solid immunity and most of the 
deaths occur in young children in endemic areas and 
in infected adults without previous exposure to 
malaria. Immunity builds up in the course of succes- 
sive infections and sterile immunity is probably never 
achieved. In endemic areas clinically significant 
malaria becomes infrequent in adults with the excep- 
tion of pregnant women; however transient para- 
sitaemia is still observed. 
Asexual blood stage proliferation is responsible for 
all the morbidity and mortality associated with 
malaria in man and is the obvious target for the 
development of malaria vaccines. In practical terms 
one may consider two kinds of asexual blood stage 
vaccines: first, a fully efficient vaccine able to confer 
sterile immunity; such a vaccine has to do better than 
nature and represents a dif%cult challenge: second, a 
vaccine capable of stimulating a degree of protection 
which would enable the vaccinated individuals to 
overcome subsequent infection without suffering 
major illness. In endemic areas this kind of vaccine 
would transform the immune system of an unpro- 
tected child into that of an adult having experienced 
multiple malaria infections. 
Identification 6f antigens involved in protection; 
experimental immunization 
Immunization experiments have been carried out 
with merozoites, schizonts, or both in a variety of 
host-PZasmudium combinations, including monkeys 
immunized with P. fdca~. These experiments 
established that at least partial protection can be 
induced artificially (SIDDIQUI, 1977). Another draw- 
back of immunization experiments with sporozoites, 
asexual blood stages and gametes was the finding that 
immmity induced by these vaccines was stage spe- 
cilic. Immunity to sporozoites is without effect on 
parasitaemia, which may develop if some sporozoites 
evade immunity, and asexual blood stage vaccine did 
not prevent the development of exoery&roc@c schi- 
zogony in the liver. The production of whole merozo- 
ites or schizonts, or both, in sufiicient amounts for 
large scale immunization programmes i  not feasible. 
In addition these crude preparations contain foreign 
material such as red blood cell membranes which are 
likely to induce adverse autoimmune reactions. They 
may also contain parasite components involved in 
suppressive responses or elicit diffuse immune re- 
sponses. 
For these reasons ubsequent efforts were aimed at 
the development of subunit vaccines. This implicates 
as a first step the identification of parasite components 
which may induce protective responses. This search 
was greatly facilitated by the development by TIMGER 
& JENSEN (1976) of an in vizro method for the culture 
of P. fukipurwn erykoqdc stage:, which made it 
possible for a number of laboratories to analyse in 
detail individual components of both sexual and 
asexual stages of P. fakipawn and to conduct 
biological assays routinely. 
Several hundreds of asexual blood stage compo- 
nents are able to raise an immune response but very 
few of them are helnful for the host. It is therefore a 
difficult challenge io select the appropriate compo- 
nents and several frequently complementary 
approaches have been selected, including the fol- 
lowing. 
(i) Identilication of antigens expressed at the 
surface of merozoites and schizonts by surface 
labelling. 
(ii) Identification of parasite components preferen- 
tially recognized by sera of immune adults or sera of 
motected monkeys. 
(iii) Identification of parasite components recog- 
nized bv monoclonal antibodies Ible to inhibit the 
growth -of asexual blood stages in v&o. 
(iv) Search for parasite molecules with crucial 
functions for the development of the parasite or 
invasion of erythrocytes by merozoites. 
(v) Finally, more recently, systematic immuniza- 
tion of experimental monkeys with P. fakipanm 
components eluted from gels, determination of the 
amino acid sequences of components associated with 
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protection, and biochemical synthesis of correspond- 
ing peptides which in turn are used for immunization 
of monkeys (PATARROYO et al., 1987). 
From these investigations a number of potential 
candidates emerged and we shall now briefly describe 
some of their characteristics. 
Merozoite surface antikwu 
A protein -with a molecular mass in the range of 
190-230 kDa has been identified at the surface of 
schizonts in several malaria species. This protein is 
processed into a smaller molecule which is the main 
component exposed at the surface of merozoites. In 
mice, immunization with this protein purified from 
P. yoelii extract was able to protect the animals from 
challenge infection (HOLDER & FREEMAN, 1981). The 
corresponding protein of P. fakiparum has an.appa- 
rent molecular mass of 180-200 kDa and is processed 
into an 83 kDa merozoite surface polypeptide (HOL- 
DER & FREEMAN, 1982). By using a panel of 
monoclonal antibodies it was shown that this molecule 
presented a considerable degree of antigenic diversity 
(MCBRIDE et al.. 1985). The gene codinn for this 
protein has been cloned from several P. Jalciparum 
isolates and can be divided into several blocks ranging 
in homology from 10 to 87% at the amino acid levels 
(MCKAY et al., 1985). Several immunization trials 
have been conducted with this protein in monkeys 
and have indicated that partial to almost complete 
protection can be induced by this protein adminis- 
tered with Freund’s complete adjuvant (PERRIN et al., 
1984; HALL et al., 1984; SIDDIQUI et al., 1987). 
Immunization with synthetic polypeptides corres- 
ponding to the conserved NH2 part of the molecule 
and to another area (aa 277-287) also confers partial 
protection on immunized monkeys (CHEUNG et al., 
1986; PATARROYO et al., 1987). Other antigens are 
also expressed at the surface of the merozoite but they 
have not been fully characterized. 
Antigens associated eLnth the membrane of infected 
erythrocytes. 
Several proteins associated with the membrane of 
red blood cells containina P. falcitwum asexual blood 
stages have been &racier&d, m particular a ring- 
infected erythrocyte surface antigen (RESA) and 2 
nroteins associated with knobs (electron dense pro- 
&erances of the plasma membrane of infected 
ervthrocvtes): KAHRP (knob-associated histidine- 
rich prdteir) and MESA (mature parasite-infected 
erythrocyte surface antigen). 
RESA has a molecular mass of 155 kDa. This 
antigen is synthesised in trophozoites, accumulates in 
micronemes (apical structures of merozoites) and, 
following invasion, becomes associated with the 
membrane of r&r-mfected ervthrocvtes (PERLMANN 
et al., 1984; BROW et al., 1985). Am&odies against 
RESA inhibit the nroliferation of asexual blood stages 
of P. falciparum in vitro and it was postulated that 
these antibodies interfere with the invasion process. 
The gene coding for RESA has been cloned and it was 
found that the molecule contained two blocks of 
renetitive seauences which are the immunodominant 
epitopes in t&ms of antibody responses (FAVAROLO et 
al.. 1986: KEMP et al.. 1987). Interestinelv. anti- 
bodies directed against ‘the repeat areas c&+react 
with at least 6 other asexual blood stage components. 
Monkeys have been immunized with synthetic pep- 
tides corresponding to the repeated sequences and 
with fusion proteins corresponding to various areas of 
the molecule. Some groups of monkeys were pro- 
tected (COLLINS et al:, 1986) but the most active area 
of the molecule is sull not identified (R. E. Anders, 
personal communication). 
Ervthrocvtes containing mature tronhozoites and 
schhnts of P. fukipurzkadhere throw& the knobs 
to endothelial cells hnina venules in deeD tissues. This 
cytoadherence of parasitized erythrkytes prevents 
their passage through the spleen and their eventual 
destruction in this organ. Cytoadherence can be 
inhibited by antisera in a strain specific manner but an 
antigenically invariant epitope was also identified at 
the surface of infected erythrocytes isolated from 
Gambian patients (MARSH & HOWARD, 1986). Several 
proteins are present in the knobs and two of them, 
KAHRP and MESA, have been characterized and 
part of the gene codmg for them has been cloned. 
These two proteins present a size variation for various 
P. fulciparum isolates of 85-105 kDa for KAHRP and 
240-300 kDa for MESA. These proteins contain 
repeated amino acid sequences and differ antigenical- 
ly among isolates. 
Rhoptty proteins. 
Rhoptries are apical organelles of merozoites which 
release their content into erythrocytes at the time of 
invasion. Monoclonal antibodies directed against a 
rhoptry component of P. yoelii reduce the virulence of 
infection following passive transfer and monoclonal 
antibodies directed against 41-82 kDa rhoptry com- 
ponents of P. fakiparum inhibit the growth of asexual 
blood stages in vitro (PENN & DAYAL, 1982). The 
82 kDa protein is processed into components of 76 
and 65 kDa and is not related to the 41 kDa 
polypeptide (BRAUN-BRETON et al., 1986). Interes- 
tingly the functional activity of both of these compo- 
nents has been clarified: the 82-76 kDa component is 
a protease and the 41 kDa component displays 
aldolase activity (U. Certa, personal communication). 
In addition, immunization of monkeys with either of 
these peptides induces protective immunitv (DUBOIS 
et al.,- i984; PERRIN ei al., 1985). - 
Another rhomrv antigen of P. falcibarum has been 
characterized. This pro&n is located in the peduncle 
of the rhontries. is svnthesised at the tronhozoite staee 
in the f&m of a -240 kDa polypepiide which :s 
processed into a 255 kDa polypeptide during schizo- 
gony. The 225 kDa protein is recovered quantitative- 
ly in the supematant of culture following merozoite 
invasion (DUBREMETZ et al., 1988). A third set of 
rhoptry proteins is composed of three proteins of 
molecular mass of 105. 130 and 140 kDa which are 
co-precipitated. These ‘components are unrelated, as 
shown by protease digestion of individual components 
and by epitope mapping. The 225 kDa protein and 
proteins of the 105/130/140 kDa complex have not 
been evaluated in immunization trials in monkeys. 
Other candidates 
Several other proteins of asexual blood stages are 
considered as candidates for the development of 
asexual blood stage vaccine on the basis of their 
functional activity or on the basis of successful 
immunization trials. Several parasite components 
have been shown to bind to erythrocyte membranes or 
to glycophorin A, or both, which may act as binding 
l&and for merozoites (JUNGERY et al., 1983). These 
polypeptides are obvious candidates for vaccine de- 
velopment but, like many other P. falciparum 
polypeptides, may present marked antigenic diversity 
among various isolates. Another potential candidate is 
the malaria transferrin receptor which has been 
identified at the surface of erythrocytes. The parasite 
requires exogenous iron and the receptor internalizes 
and transports bound ferrotransferrin to the in- 
tracellular parasite. The potential of this protein for 
vaccine development will depend on its divergence 
from the hum& receptor (RODRIGUEZ & JUNI~RY, 
1986). Another potential candidate is a parasitophor- 
ous vacuole antigen of P. fakiparum with a molecular 
mass of 126-140 kDa. This nrotein is cleaved uoon 
schizont rupture into 3 major&tgments of SO,47 ‘and 
18 kDa which are released into culture medium 
(DELPLACE et al., 1985). Part of the gene codinn for 
this protein has been cloned and sh&vn to code for 
amino acid repeats; one of the stretch of repeats being 
composed of polyserine repeats. Monkeys immunized 
with the 126140 kDa protein are protected from a 
lethal P. falciparum challenge (PRRRtN et al., 1984). 
Synthetic peptides as immunagens 
Peptides derived from constant portions of the 
83 kDa merozoite surface protein have been used as 
immunogen after coupling to carrier proteins 
(CHEIJNG et al.. 1986: PATARROVO et al.. 1987). 
Similar methods have been applied using 
polypeptides corresponding to repeats of KESA (COL- 
LING et al.. 1986) and to the NH, terminal uortion of 2 
parasite components charactehed only by their 
apparent molecular mass of 55 and 35 kDa (PATAR- 
ROY0 et al., 1987). A partial protection of a lower 
magnitude than that observed following immuniza- 
tion with the complete corresponding antigens was 
observed. The antibody titres obtained using synthe- 
tic peptides were also relatively low. Finally there is 
the problem of boostina the resuonse following 
natural exposure of the immunized ‘mdividuals. Th: 
development of antibodies requires T cell help which 
was provided in the above immunizations by foreign 
carriers, which will not be available to induce a 
booster effect followinfz malaria infection. In this 
respect T cell activating sites present in the parasite 
molecules hould be present in the vaccine rather than 
foreign material. In relation to T cell sites, their 
selection may be a complex process since response to 
some of them is restricted by the major histocompati- 
bility complex (DEL GIUDICE et al., 1986) and others 
may be present on areas of the parasite molecules 
presenting sequence variations among isolates. These 
elements suggest that the development of malaria 
vaccines based on asexual blood stage components 
should rely not only on identification of parasite target 
antigens and their production but also on the molecu- 
lar interaction between the parasite components and 
the host effector mechanisms. In this respect it is still 
not clear whether the best vaccine should be based on 
full length parasite components (eventually with 
excision of limited parts of the molecules involved in 
negative regulation or containing repeats), these full 
length proteins having the advantage of containing 
multiple B and T cell epitopes, or on a cocktail of 
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synthetic peptides with complementary function. The 
identification of B and T cell enitones as well as the 
interaction of the parasite compbnetits with the major 
histocompatibility complex is the subject of numerous 
promising investigations. 
Discussion and Conclusion 
It seems appropriate, following the description of 
candidate antigens for the development of asexual 
blood stage vaccines, to place this development in the 
context of Plusmadium-host relationships. There is an 
apparent contradiction between the number of poten- 
tial targets on malaria parasites for host effector 
mechanisms and the slow development of protective 
immunity following experimental immunization. This 
contradiction is the reflection of the extremely suc- 
cessful adaptation of malaria parasites to the verte- 
brate hosts. Most of the factors which are involved in 
parasite survival within the host are well known, such 
as intracellular development of the parasite, parasite 
antigenic diversity or variation, or both, polyclonal 
activation of the host immune system, and immuno- 
suppression, but they have been described until 
recently from the phenomenological aspect only. 
Development of in vitro culture techniques, monoc- 
lonal antibodies, T cell cloning and -recombinant 
DNA technoloev have nrovided the tools to analvse 
these phenomena t the-molecular levels on both ihe 
parasite and the immune system sides (Km et al., 
1987; DEL GIUDICE et al., 1986). 
Antigenic diversity among various isolates has been 
studied at the molecular level for several components 
of asexual blood stage parasites and in particular for 
the 83 kDa protein which is the major P. fakipum 
merozoite surface component and for parasite compo- 
nents exposed at the surface of erythrocytes contain- 
ing mature parasites. These components are the 
subject of intense pressure by the immune system and 
their high concentraton in the blood of infected 
individuals increases the opportunity for the selection 
of mutants. Another characteristic of malaria proteins 
is the presence of tandemly repeated amino acids 
which are frequently dominant in term of antibody 
responses. These repeats may vary or may be deleted 
(A. Anders & U. Certa, wrsonal communications). It
has been postulated that these repeats divert ‘the 
immune response (the smokescreen model) and pre- 
vent the development of truly protective responses 
(KRMP et al., 1987). In addition they may be involved 
in polyclonal B and T cell activation and play a role in 
the immunosuppression associated with malaria. The 
extent of antigenic diversity observed in malaria can 
have direct consequences on primary and secondary 
responses to the infection which require collaboration 
of B and T cells whose responses can be exquisitely 
specific for a given epitope. Another mechanism 
capable of preventing the development of specific 
protective responses on one hand and on the other 
hand favouring the development of autoantibodies i  
the homology of parasite sequences with human 
proteins. This has been shown, for example, for the 
region II of the circumsporozoite protein and for the 
83 kDa merozoite surface protein (CHEUNG et al., 
1986). 
All these elements focus our attention on the 
necessity for both basic and applied research and for a 
multidisciplinary approach to the development of 
malaria vaccines. 
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